Yukiko Kamiya
Overview
Explore the profile of Yukiko Kamiya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
1027
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsuboi T, Hattori K, Ishimoto T, Imai K, Doke T, Hagita J, et al.
Mol Ther Nucleic Acids
. 2025 Mar;
36(1):102497.
PMID: 40083647
[This corrects the article DOI: 10.1016/j.omtn.2024.102387.].
2.
Tsuboi T, Hattori K, Ishimoto T, Imai K, Doke T, Hagita J, et al.
Mol Ther Nucleic Acids
. 2025 Jan;
36(1):102387.
PMID: 39850319
Nucleic acid medicine encompassing antisense oligonucleotides (ASOs) has garnered interest as a potential avenue for next-generation therapeutics. However, their therapeutic application has been constrained by challenges such as instability, off-target...
3.
Takekawa G, Nakasone Y, Kamiya Y, Asanuma H, Terazima M
Phys Chem Chem Phys
. 2025 Jan;
27(6):3302-3312.
PMID: 39849913
Reaction and interaction dynamics of azobenzene-tethered DNA (photoresponsive DNA) with T7 RNA polymerase (T7RNAP) were studied after photoisomerization of azobenzene from the - to -forms using the transient grating (TG)...
4.
Kamiya Y, Lao S, Ariyoshi J, Sato F, Asanuma H
Chem Commun (Camb)
. 2024 Jan;
60(10):1257-1260.
PMID: 38175608
Homopurine strands are known to form antiparallel triplexes stabilized by G*G and A*A Hoogsteen pairs, which have two hydrogen bonds. But there has been no report on the parallel triplex...
5.
Zhu H, Kamiya Y, Asanuma H
ACS Chem Biol
. 2023 Oct;
18(10):2281-2289.
PMID: 37789826
Anti-miRNA oligonucleotides (anti-miRs) effectively and specifically inhibit the function of individual miRNAs and have the potential to serve as a novel class of nucleic acid therapeutic. However, the details of...
6.
Kamiya Y, Satoh T, Kodama A, Suzuki T, Murayama K, Kashida H, et al.
Commun Chem
. 2023 Jan;
3(1):156.
PMID: 36703369
Xeno nucleic acids, which are synthetic analogues of natural nucleic acids, have potential for use in nucleic acid drugs and as orthogonal genetic biopolymers and prebiotic precursors. Although few acyclic...
7.
Sato F, Kamiya Y, Asanuma H
J Org Chem
. 2023 Jan;
88(2):796-804.
PMID: 36608022
We previously synthesized phosphoramidite monomers bearing Boc-protected 2,6-diaminopurine (D) and 2-methyl-4-methoxybenzyl-protected 2-thiouracil (sU) as building blocks for the preparation of pseudo-complementary serinol nucleic acids (SNAs). Since SNA is stable under...
8.
Asanuma H, Kamiya Y, Kashida H, Murayama K
Chem Commun (Camb)
. 2022 Feb;
58(25):3993-4004.
PMID: 35107445
DNA and RNA have significance as genetic materials, therapeutic potential, and supramolecular properties. Advances in nucleic acid chemistry have enabled large-scale synthesis of DNA and RNA oligonucleotides and oligomers of...
9.
Kamiya Y, Kamimoto H, Zhu H, Asanuma H
Sensors (Basel)
. 2021 Apr;
21(5).
PMID: 33806517
microRNAs (miRNAs) are small non-coding ribonucleic acids (RNAs), which regulate gene expression via the RNA interference (RNAi) system. miRNAs have attracted enormous interest because of their biological significance and disease...
10.
Kamiya Y, Takeyama Y, Mizuno T, Satoh F, Asanuma H
Int J Mol Sci
. 2020 Jul;
21(15).
PMID: 32717920
Small interfering RNA (siRNA) has been recognized as a powerful gene-silencing tool. For therapeutic application, chemical modification is often required to improve the properties of siRNA, including its nuclease resistance,...